|
|
Article: Cytovance Biologics Selects Sartorius BBI Systems Bioreactors for its Oklahoma City Biopharmaceutical Manufacturing Facility; Completion of cGMP Facility Validation Anticipated in the Summer of 2006.
- Article from:
- Business Wire
- Article date:
- November 22, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
OKLAHOMA CITY -- Cytovance Biologics announced today that it has selected Sartorius BBI Systems Inc., a leading designer and manufacturer of bioprocess equipment and automation systems, to supply bioreactors for its cGMP biopharmaceutical production facility in Oklahoma City, Okla.
Cytovance Biologics will install two Biostat(R) DC industrial bioreactor systems in support of its contract biopharmaceutical process development and manufacturing business. The Biostat D-100C (100 L working volume) and Biostat D-500C (500 L working volume) systems will be located in dedicated cell culture production suites within Cytovance's 44,000 sq. ft. cGMP production facility ...